Table of Contents
ISRN Hematology
Volume 2013 (2013), Article ID 904201, 7 pages
http://dx.doi.org/10.1155/2013/904201
Clinical Study

Survival and Prognostic Factors for AIDS and Non-AIDS Patients with Non-Hodgkin’s Lymphoma in Bahia, Brazil: A Retrospective Cohort Study

1Hospital Universitário Professor Edgard Santos, Universidade Federal da Bahia, Rua Augusto Viana s/n, 40110-060 Salvador, BA, Brazil
2Serviço de Hematologia, Núcleo de Oncologia da Bahia, Avenida Adhemar de Barros 123, Ondina, 40170-110 Salvador, BA, Brazil

Received 21 June 2013; Accepted 7 August 2013

Academic Editors: Z. Duan and Y. K. Lee

Copyright © 2013 Estela Luz et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. N. Phillips, M. Youle, F. Lampe et al., “CD4 cell count changes in individuals with counts above 500 cells/mm3 and viral loads below 50 copies/mL on antiretroviral therapy,” AIDS, vol. 16, no. 7, pp. 1073–1075, 2002. View at Publisher · View at Google Scholar · View at Scopus
  2. L. Gil, G. Martínez, I. González et al., “Contribution to characterization of oxidative stress in HIV/AIDS patients,” Pharmacological Research, vol. 47, pp. 217–224, 2003. View at Google Scholar
  3. C. Smith, S. Lilly, K. P. Mann et al., “AIDS-related malignancies,” Annals of Medicine, vol. 30, no. 4, pp. 323–344, 1998. View at Google Scholar · View at Scopus
  4. A. Grulich, X. Wan, M. Law, M. Coates, and M. Kaldor, “Risk of cancer in people with aids,” AIDS, vol. 13, no. 7, pp. 839–843, 1999. View at Publisher · View at Google Scholar · View at Scopus
  5. C. Wood and W. Harrington Jr., “AIDS and associated malignancies,” Cell Research, vol. 15, no. 11-12, pp. 947–952, 2005. View at Publisher · View at Google Scholar · View at Scopus
  6. M. W. Otieno, C. Banura, E. Katongole-Mbidde et al., “Therapeutic challenges of AIDS-related non-Hodgkin's lymphoma in the United States and East Africa—a review,” Journal of the National Cancer Institute, vol. 94, no. 10, pp. 718–732, 2002. View at Google Scholar · View at Scopus
  7. A. M. Levine, “Acquired immunodeficiency syndrome-related lymphoma: clinical aspects,” Seminars in Oncology, vol. 27, no. 4, pp. 442–453, 2000. View at Google Scholar · View at Scopus
  8. E. A. Engels, R. M. Pfeiffer, J. J. Goedert et al., “Trends in cancer risk among people with AIDS in the United States 1980–2002,” AIDS, vol. 20, no. 12, pp. 1645–1654, 2006. View at Publisher · View at Google Scholar · View at Scopus
  9. J. L. Long, E. A. Engels, R. D. Moore, and K. A. Gebo, “Incidence and outcomes of malignancy in the HAART era in an urban cohort of HIV-infected individuals,” AIDS, vol. 22, no. 4, pp. 489–496, 2008. View at Publisher · View at Google Scholar · View at Scopus
  10. R. J. Bedimo, K. A. McGinnis, M. Dunlap, M. C. Rodriguez-Barradas, and A. C. Justice, “Incidence of non-AIDS-defining malignancies in HIV-infected versus noninfected patients in the HAART era: impact of immunosuppression,” Journal of Acquired Immune Deficiency Syndromes, vol. 52, no. 2, pp. 203–208, 2009. View at Publisher · View at Google Scholar · View at Scopus
  11. C. Wood and W. Harrington Jr., “AIDS and associated malignancies,” Cell Research, vol. 15, no. 11-12, pp. 947–952, 2005. View at Publisher · View at Google Scholar · View at Scopus
  12. O. C. Baiocchi, G. W. Colleoni, E. V. Navajas et al., “Impact of highly active antiretroviral therapy in the treatment of HIV-infected patients with systemic non-Hodgkin's lymphoma,” Acta Oncologica, vol. 41, no. 2, pp. 192–196, 2002. View at Publisher · View at Google Scholar · View at Scopus
  13. J. R. Marins, L. F. Jamal, S. Y. Chen et al., “Dramatic improvement in survival among adult Brazilian AIDS patients,” AIDS, vol. 17, no. 11, pp. 1675–1682, 2003. View at Publisher · View at Google Scholar · View at Scopus
  14. S. Rosenberg, “Validity of the Ann Arbor staging classification for the non-Hodgkin's lymphomas,” Cancer Treatment Reports, vol. 61, no. 6, pp. 1023–1027, 1977. View at Google Scholar · View at Scopus
  15. M. M. Oken, R. H. Creech, D. C. Tormey et al., “Toxicity and response criteria of the Eastern Cooperative Oncology Group,” The American Journal of Clinical Oncology, vol. 5, pp. 649–655, 1982. View at Google Scholar
  16. “A predictive model for aggressive non-Hodgkin's lymphoma. The International Non-Hodgkin's Lymphoma Prognostic Factors Project,” The New England Journal of Medicine, vol. 329, pp. 987–994, 1993.
  17. C. S. Rabkin and F. Yellin, “Cancer incidence in a population with a high prevalence of infection with human immunodeficiency virus type 1,” Journal of the National Cancer Institute, vol. 86, no. 22, pp. 1711–1716, 1994. View at Google Scholar · View at Scopus
  18. B. Kiely, J. O'Flaherty, S. Surah et al., “HIV-related malignancies pre- and post-highly active antiretroviral therapy: experiences in an inner city tertiary referral centre,” International Journal of STD and AIDS, vol. 21, no. 5, pp. 332–336, 2010. View at Publisher · View at Google Scholar · View at Scopus
  19. J. Pereira, A. E. Hallack Neto, L. F. Pracchia et al., “Quimioterapia associada à terapia anti-retroviral de alta eficácia no tratamento dos linfomas não-Hodgkin agressivos relacionados à Síndrome da Imunodeficiência Adquirida,” Revista Brasileira de Hematologia e Hemoterapia, vol. 26, pp. 177–182, 2004. View at Google Scholar
  20. L. Barreto, D. Azambuja, and J. C. de Morais, “Expression of immunohistochemical markers in patients with AIDS-related lymphoma,” The Brazilian Journal of Infectious Diseases, vol. 16, no. 1, pp. 74–77, 2012. View at Publisher · View at Google Scholar · View at Scopus
  21. M. Simcock, M. Blasko, U. Karrer et al., “Treatment and prognosis of AIDS-related lymphoma in the era of highly active antiretroviral therapy: findings from the Swiss HIV Cohort Study,” Antiviral Therapy, vol. 12, no. 6, pp. 931–939, 2007. View at Google Scholar · View at Scopus
  22. M. Moreira, A. Ramos, E. M. Netto, and C. Brites, “Characteristics of co-infections by HCV and HBV among Brazilian patients infected by HIV-1 and/or HTLV-1,” The Brazilian Journal of Infectious Diseases, 2013. View at Publisher · View at Google Scholar
  23. D. H. Kim, J. H. Baek, Y. S. Chae et al., “Absolute lymphocyte counts predicts response to chemotherapy and survival in diffuse large B-cell lymphoma,” Leukemia, vol. 21, no. 10, pp. 2227–2230, 2007. View at Publisher · View at Google Scholar · View at Scopus
  24. R. Kim, M. Emi, K. Tanabe, and K. Arihiro, “Tumor-driven evolution of immunosuppressive networks during malignant progression,” Cancer Research, vol. 66, no. 11, pp. 5527–5536, 2006. View at Publisher · View at Google Scholar · View at Scopus
  25. C. Choi, H. Sung, K. Park et al., “Early lymphopenia as a risk factor for chemotherapy-induced febrile neutropenia,” The American Journal of Hematology, vol. 73, no. 4, pp. 263–266, 2003. View at Publisher · View at Google Scholar · View at Scopus
  26. I. Ray-Coquard, C. Borg, T. Bachelot et al., “Baseline and early lymphopenia predict for the risk of febrile neutropenia after chemotherapy,” The British Journal of Cancer, vol. 88, no. 2, pp. 181–186, 2003. View at Publisher · View at Google Scholar · View at Scopus